$ADTX

Aditxt, Inc.

0
0
1

No SEC Form 4 filings for $ADTX in the last 30 days.

Med

Aditxt (NASDAQ: ADTX) Q1 loss deepens as equity turns negative and going concern raised

Aditxt (ADTX) reported a significant net loss of $16.19 million in Q1 2026, exacerbated by operating expenses and a substantial non-cash loss from derivative liabilities. The company's cash balance dwindled to $268,852, and its stockholders' equity turned into a $35.17 million deficit, leading management to express substantial doubt about its ability to continue as a going concern. ADTX is relying on new financings and is facing potential delisting from Nasdaq due to non-compliance with the minimum bid price rule.

Aditxt Enacts Reverse Stock Split to Maintain Nasdaq Listing

Aditxt (ADTX) completed a 1-for-27 reverse stock split, effective May 15, 2026, with trading under new split-adjusted terms on Nasdaq starting May 18, 2026. This action, approved by shareholders, aims to regain compliance with Nasdaq's minimum bid price requirement and reduce the outstanding share count from 13.8 million to approximately 510,000. The move also includes adjustments to equity-linked securities and introduces a new CUSIP, helping to stabilize the company's Nasdaq listing status and access to public capital markets.

Aditxt Faces Nasdaq Delisting After Extended Bid-Price Noncompliance

Aditxt (ADTX) is facing delisting from The Nasdaq Capital Market because its share price remained below $1 for 30 consecutive business days. Due to multiple reverse stock splits exceeding a cumulative ratio of 250-to-1 within the past two years, the company is not eligible for the standard 180-day grace period. Aditxt plans to appeal the decision to a Nasdaq Hearings Panel to temporarily stay the delisting, but investors face uncertainty regarding the company's ability to maintain its listing.